Les Turner ALS Foundation Navigation
  • ALS Services
    • Coronavirus (COVID-19) Updates
      • COVID-19 & ALS: Frequently Asked Questions
      • Care Recommendations for Respiratory Issues
    • Support Services Team
    • Support Groups
      • The Jill and Dennis Smith ALS Education and Awareness Fund
    • Communication Passport
    • Grant Programs & Equipment Loans
      • Applying for Benefits
      • Walter Boughton Foundation Grant
      • Dan Nelson ALS Respite Fund
      • Assistive Technology Grant
      • The Stuart Rosen ALS Transportation Fund
    • National ALS Registry
  • ALS Center
    • Les Turner ALS Center at Northwestern Medicine
    • Lois Insolia ALS Clinic
    • Clinical Trials & Studies
    • Les Turner Symposium on ALS
  • ALS Education
    • What is ALS?
    • ALS Learning Series
    • My ALS Decision ToolTM
    • ALS & Activities of Daily Living
    • ALS & Breathing
    • ALS & Communication
    • ALS & Home Modifications
    • ALS & Mobility
    • ALS & Nutrition
    • ALS & Children
    • ALS & Caregiving
    • ALS & Caregiver Self-Care
    • ALS & Relationships, Sex and Intimacy
    • Trusted Resources to Learn About ALS
  • Events
    • Calendar of Events
    • Hope Through Caring Gala
    • Team Race for ALS
    • ALS Walk for Life
    • Celebration of Life
    • All in for ALS Casino Night
    • Strike Out ALS 5K
  • Get Involved
    • Ways to Donate
      • Make an Online Donation
      • Matching Gifts/Workplace Giving
      • Stock Donations
      • Planned Giving
      • Become a Corporate Sponsor
    • Volunteer
    • Young ProfessionALS Group
    • Gratitude Group
    • Fundraise Your Way
    • Tag Days
    • ALS Awareness Month
  • About Us
    • History, Mission & Vision
    • Board of Directors
    • Staff
    • International Alliance
    • Financial Statements
    • Contact Us
  • ALS News
  • Donate
  • Search
  • ALS Services
    • Coronavirus (COVID-19) Updates
      • COVID-19 & ALS: Frequently Asked Questions
      • Care Recommendations for Respiratory Issues
    • Support Services Team
    • Support Groups
      • The Jill and Dennis Smith ALS Education and Awareness Fund
    • Communication Passport
    • Grant Programs & Equipment Loans
      • Applying for Benefits
      • Walter Boughton Foundation Grant
      • Dan Nelson ALS Respite Fund
      • Assistive Technology Grant
      • The Stuart Rosen ALS Transportation Fund
    • National ALS Registry
  • ALS Center
    • Les Turner ALS Center at Northwestern Medicine
    • Lois Insolia ALS Clinic
    • Clinical Trials & Studies
    • Les Turner Symposium on ALS
  • ALS Education
    • What is ALS?
    • ALS Learning Series
    • My ALS Decision ToolTM
    • ALS & Activities of Daily Living
    • ALS & Breathing
    • ALS & Communication
    • ALS & Home Modifications
    • ALS & Mobility
    • ALS & Nutrition
    • ALS & Children
    • ALS & Caregiving
    • ALS & Caregiver Self-Care
    • ALS & Relationships, Sex and Intimacy
    • Trusted Resources to Learn About ALS
  • Events
    • Calendar of Events
    • Hope Through Caring Gala
    • Team Race for ALS
    • ALS Walk for Life
    • Celebration of Life
    • All in for ALS Casino Night
    • Strike Out ALS 5K
  • Get Involved
    • Ways to Donate
      • Make an Online Donation
      • Matching Gifts/Workplace Giving
      • Stock Donations
      • Planned Giving
      • Become a Corporate Sponsor
    • Volunteer
    • Young ProfessionALS Group
    • Gratitude Group
    • Fundraise Your Way
    • Tag Days
    • ALS Awareness Month
  • About Us
    • History, Mission & Vision
    • Board of Directors
    • Staff
    • International Alliance
    • Financial Statements
    • Contact Us
  • ALS News
  • Donate
  • Search

Post Archive by Month

Below you'll find a list of all posts from May, 2017

Radicava FAQs

lesturner May 22, 2017 Foundation Blog, Home Page, Research News, Support Services

Les Turner ALS Research and Patient Center at Northwestern Medicine On May 5, the FDA approved a new drug to treat ALS. Radicava™ (also known as Edaravone) is the first approved ALS-specific drug since Riluzole, which was approved 22 years …

Read More

New Gene Identified in ALS

lesturner May 16, 2017 Foundation Blog, Home Page, Research News

(May 15, 2017)- For the first time, a variant in UBQLN4 gene has been associated with Lou Gehrig’s disease or amyotrophic lateral sclerosis (ALS) – a progressive disease resulting in the loss of nerve cells that control muscle movement, which …

Read More

MT Pharma America Announces FDA Approval of RADICAVA™ (Edaravone)

lesturner May 8, 2017 Advocacy, Foundation Blog, Home Page

Just today, we learned the FDA has approved the first new drug for ALS in 22 years! The new drug is called Radicava and has been demonstrated to slow decline of physical function by 33 percent. The timing of this …

Read More

The National ALS Biorepository Launched – “Learn How to Participate”

lesturner May 1, 2017 Foundation Blog, Home Page, Research News

One of the questions that people living with ALS often ask is – what can I do to help ALS Research? ALS patients can do that, with a personal contribution to the National ALS Registry (Registry) – in the newly …

Read More

Recent Posts

  • Faces of ALS: Redefining advocacy for a new generation
  • January 2023 Foundation eNews
  • On the passing of Lin Brehmer, a true friend of the ALS community
  • Faces of ALS: Giving New Meaning to ‘an ALS Journey’ …Road Trip!
  • Faces of ALS: Hope Through Painting

Archives

  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • February 2016
  • September 2015
  • June 2015
  • May 2015
  • April 2015
  • January 2015
  • November 2014
  • August 2014
  • March 2014
  • February 2014
  • February 2013
  • October 2008

Categories

  • Advocacy
  • Donor Spotlights
  • Faces of ALS
  • Foundation Blog
  • Foundation eNews
  • Home Page
  • Research News
  • Support Services

Les Turner ALS Foundation

Les Turner ALS Foundation

info@lesturnerals.org
847 679 3311

5550 W Touhy Avenue,
Suite 302; Skokie, IL
60077-3254

 

© Les Turner Amyotrophic Lateral Sclerosis Foundation, Ltd.

The Les Turner ALS Foundation is a non-profit corporation under section 501(c)(3) of the U.S. Internal Revenue Code, EIN 36-2916466

Accreditation

Better Business Bureau - Accredited Charity   Member Community Health Charities     Charity Navigator

Affiliates

Northwestern Medicine Feinberg School of Medicine - Les Turner ALS Center
International Alliance of ALS/MND Associations

Site Credit

Distortion Design

  • Privacy Policy
  • Contact Us
DONATE